Generelt var typen og hyppigheden af bivirkninger rapporteret hos patienter med en lav kropsvægt (≤ 60 kg) de samme som hos dem med en højere (> 60 kg), men korrigeret for placebo var hyppigheden af følgende almindelige bivirkninger højere i gruppen af patienter med lav kropsvægt end hos de øvrige patienter: kvalme (14% mod 2%), opkastning (6% mod 1%) og hypotension (4% mod 2%).
In general, the type and frequency of adverse events reported in patients with low body weight (≤ 60 kg) were similar to those of patients with higher weight (> 60 kg); however, the placebo- corrected frequencies of the following common adverse events were higher in low body weight than heavier patients: nausea (14% versus 2%), vomiting (6% versus 1%), and hypotension (4% versus 2%).